NEWS: 公告在東京證券交易所JASDAQ標準市場新上市

市場調查報告書

臉部美學的全球市場:2020年∼2027年

Global Facial Aesthetics Market - 2020-2027

出版商 DataM Intelligence 商品編碼 968964
出版日期 內容資訊 英文 223 Pages
商品交期: 最快1-2個工作天內
價格
臉部美學的全球市場:2020年∼2027年 Global Facial Aesthetics Market - 2020-2027
出版日期: 2020年09月30日內容資訊: 英文 223 Pages
簡介

全球臉部美學市場,預計從2020年到2027年以21.0%的年複合成長率繼續成長。

不論已開發國家、新興國家皆對美容的興趣高漲,2017年美國所進行的外科及微創的美容整形手術,比前一年是多2%的1,750萬件。市場擴大的原動力,是研究開發的發展,法規當局的認證數量的增加,老年人口的增加,污染等環境因素的早期老化等要素。

本報告提供全球臉部美學市場調查,市場力學,產業的要素,各產品,各用途,各終端用戶,各地區的分析,競爭情形,企業簡介等資訊。

目錄

第1章 調查手法和範圍

第2章 市場定義和概要

第3章 摘要整理

第4章 市場力學

  • 影響市場的要素
    • 促進因素
    • 阻礙因素
    • 市場機會
    • 影響分析

第5章 產業的要素

  • 波特的五力分析
  • 開發平台分析
  • 法規與償付分析
  • 供應鏈分析
  • 產品的創新
  • 比較方案

第6章 市場分析:各產品

  • 簡介
    • 市場規模和與前一年同期比較成長率分析
    • 市場魅力指數
  • 皮膚填充劑
    • 玻尿酸
    • PMMA(聚(甲基丙烯酸甲酯))
    • 烴基磷灰石鈣(CaHA)
    • 聚左乳酸
    • 其他
  • 肉毒桿菌
  • 化學藥品的剝離
  • 微晶換膚

第7章 市場分析:各用途

  • 簡介
    • 市場規模和與前一年同期比較成長率分析
    • 市場魅力指數
  • 面部線條修正治療*
  • 疤痕治療
  • 嘴唇治療
  • 恢復量/飽滿度
  • 其他

第8章 市場分析:各終端用戶

  • 簡介
    • 市場規模和與前一年同期比較成長率分析
    • 市場魅力指數
  • 醫院*
  • 專門診所,皮膚科診所
  • 其他

第9章 市場分析:各地區

  • 簡介
    • 市場規模和與前一年同期比較成長率分析
    • 市場魅力指數
  • 北美
  • 南美
  • 歐洲
  • 亞太地區
  • 中東、非洲

第10章 競爭情形

  • 競爭模式
  • 各公司的策略分析
  • 比較產品系列分析
  • 市場上的定位/佔有率分析
  • 合併和收購分析

第11章 企業簡介

  • Allergan*
  • Galderma
  • Merz Pharmaceuticals GmbH
  • Suneva Medical
  • Dr. Korman Laboratories Ltd.
  • Sinclair Pharma
  • Teoxane
  • Laboratoires Vivacy SAS (Bloomage Biotechnology)
  • LCA Pharmaceutical
  • Integra Lifesciences

第12章 關於DataM Intelligence

目錄

Market Overview

The Global Facial Aesthetics Market is expected to grow at a high CAGR of 21.0% during the forecasting period (2020-2027).

The rising R&D initiatives in the aesthetics industry and the recent regulatory approvals are driving the growth of the market. Also, the high proportion of the geriatric population and the rising patterns of early aging due to environmental factors such as pollution are contributing to the global facial aesthetics market. The popularity of dermal fillers has grown rapidly in recent years as they rejuvenate and enhance the aesthetic improvements previously only achievable with surgery, but at lower cost and with limited-to-no recovery time.

Market Dynamics

The growing concern of people about their appearance is gradually increasing, both in the developed and the developing countries, which leads to increase in the number of cosmetic surgeries performed annually. According to the annual plastic surgery procedural statistics, there were 17.5 million surgical and minimally invasive cosmetic procedures performed in the US in 2017, with a 2% increase in the number of procedures over 2016. The rate of growing acceptance of tissue fillers is high in developed countries, however, in developing countries people are also getting more concerned with their appearance, especially with the increasing standard of living. Wrinkles are the first visible signs of aging. A face marked by furrows appears tired and neglected. Wrinkles are like small fractures of the skin, and the the aim of a filler is to fill them. Dermal fillers, also known as injectable implants, soft tissue fillers, or wrinkle fillers, are medical device implants approved by the FDA, in order to help create a smoother and/or fuller appearance in the face, including nasolabial folds, cheeks, and lips and to increase the volume of the back of the hand. The FDA has approved some dermal fillers for the restoration and/or correction of the signs of facial fat loss (lipoatrophy) in people with human immunodeficiency virus (HIV). Hence, the growing acceptance for dermal fillers is driving the growth of facial aesthetics market globally.

Market Segmentation

The demand for dermal fillers is growing as dermal fillers helps to diminish facial lines and restore volume and fullness in the face. The rising aesthetic surgeries is also driving the dermal fillers market. For instance, according to the American Society of Plastic Surgeons (ASPS), almost 18 million people underwent surgical and minimally invasive cosmetic procedures in the United States in 2018. Cosmetic surgical procedures have been on the rise in the U.S. over the past 5 years.

By type, the Hyaluronic acid accounted for the largest market share in global dermal fillers in 2018, owing to its status as the gold standard in dermal fillers and new product launches for the hyaluronic acid. The manufacturers are continuously manufacturing ne products leading to growth of the market globally. For instance, in April 2019, Merz, a global leader in medical aesthetics, has launched the Belotero ® Revive, a dermal filler product containing a unique combination of hyaluronic acid (HA) and glycerol, designed to improve hydration, elasticity and firmness of the skin and to address the appearance of fine lines. The newest addition to the Belotero ® dermal filler range, Belotero ® Revive was designed to meet the unique needs of today's aesthetic patients. Modern consumers are especially focused on skin quality and on minimizing early signs of aging, and they value skincare and aesthetic solutions that deliver natural-looking results - the so-called "no-filter" look.

Geographical Share

North America is dominating the global facial aesthetics market with the United States accounting as the major contributor to the market. The U.S. has a growing demand for botulinum toxins and dermal fillers, owing to improving lifestyles and growing preference for minimally invasive surgeries. The increasing interest toward their aesthetic appearance among consumers is driving the growth of the market. Aesthetic fillers that contain hyaluronic

acid, collagen, and polymers and particles are used to give the skin or feature a cosmetic boost.

The rapidly aging population in this region coupled with the presence of advanced technologies and skilled cosmetic surgeons drive them. According to the American Society of Plastic Surgeons, around 2.6 million procedures have been performed in the United States using soft tissue fillers in 2016, which was 2% higher than in 2015. The increase was attributed to the safe and effective minimally-invasive procedures and their lesser side-effects. As of 2016, about 30 aesthetic fillers are approved and possess HA license for sale in Canada.

Competitive Landscape

Some of the major players operating in the global facial aesthetics market are: Allergan PLC, Galderma Laboratories, L.P., Merz Pharmaceuticals GmbH, Teoxane SA, among others. Allergan is one of the major player accounting for the highest market share in 2018, as the company has a number of technologically advanced and specialized products as per varied indications due to its JUVEDERM family of dermal fillers. This range has a number of dermal fillers according to various indications such as the correction of wrinkles and enhancement of the lips. The key players are adopting several strategies such as product launches, partnership, merger and acquisition, collaborations, finding a new market in their core competency in order to stay competitive in the market.

For instance,

On January 10th 2020, Revance Therapeutics, a biotechnology company pioneering new innovations in neuromodulators for aesthetic and therapeutic indications, signed a U.S. distribution agreement with TEOXANE SA , making Revance the exclusive commercialization partner of the Swiss company's modern and innovative Resilient Hyaluronic Acid® (RHA®) technology.

In April 2019, Merz Pharma launched a new dermal filler called the Belotero Revive dermal filler, a combination of hyaluronic acid and glycerol

In April 2019, ALLERGAN launched the Juvederm VOLUX, a dermal filler aimed at the refinement of the chin and jawline

In November 2018, Galderma Laboratories, L.P. received an FDA approval for Restylane Lyft', a hyaluronic acid dermal filler used for cheek augmentation and age-related face contour deficiencies.

In December 2016, Galderma laboratories announced the FDA approval of Restylane Refyne and Restylane Defyne dermal fillers for the treatment of laugh lines.

Why Purchase the Report?

Visualize the composition of the Facial Aesthetics Market across each indication, regarding type and treatment options, highlighting the vital commercial assets and players.

Identify business opportunities in Facial Aesthetics Market by analyzing trends and co-development deals.

Excel data sheet with thousands of data points of the Facial Aesthetics Market - level 4/5 segmentation.

PDF report with the most relevant analysis cogently put together after exhaustive qualitative interviews and in-depth market study.

Product mapping in excel for the principal products of all major market players

Target Audience

Equipment Suppliers/ Buyers

Service Providers/ Buyers

Industry Investors/Investment Bankers

Education & Research Institutes

Research Professionals

Emerging Companies

Manufacturers

Table of Contents

1. Facial Aesthetics Market Methodology and Scope

  • 1.1. Research methodology
  • 1.2. Scope of the Report

2. Facial Aesthetics Market Definition and Overview

3. Facial Aesthetics Market - Executive Summary

  • 3.1. Market Snippet by Product
  • 3.2. Market Snippet by Applications
  • 3.3. Market Snippet by End-User
  • 3.4. Market Snippet by Region

4. Facial Aesthetics Market Dynamics

  • 4.1. Market Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. Increasing demand for facial aesthetics
      • 4.1.1.2. Growing adoption of tissue fillers with rising aesthetic surgeries
    • 4.1.2. Restraints
      • 4.1.2.1. Side effects associated with dermal fillers
    • 4.1.3. Opportunities
    • 4.1.4. Impact Analysis

5. Facial Aesthetics Market - Industry Factors

  • 5.1. Porter's Five Forces
  • 5.2. Pipeline Analysis
  • 5.3. Regulatory & Reimbursement Analysis
  • 5.4. Supply Chain Analysis
  • 5.5. Product Innovations
  • 5.6. Comparative Scenario (2018, 2019, 2026)

6. Facial Aesthetics Market - By Product

  • 6.1. Introduction
    • 6.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product
    • 6.1.2. Market Attractiveness Index, By Product
  • 6.2. Dermal Fillers
    • 6.2.1. Hyaluronic Acid
    • 6.2.2. PMMA (Poly(methyl methacrylate))
    • 6.2.3. Calcium Hydroxylapatite (CaHA)
    • 6.2.4. Poly-L-lactic Acid
    • 6.2.5. Others
  • 6.3. Botulinum Toxin (Botox)
  • 6.4. Chemical Peel
  • 6.5. Microdermabrasion

7. Facial Aesthetics Market - By Application

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 7.1.2. Market Attractiveness Index, By Application
  • 7.2. Facial Line Correction Treatment*
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis, US$ Million, 2018-2026 and Y-o-Y Growth Analysis (%), 2020-2027
  • 7.3. Scar Treatment
  • 7.4. Lip Treatments
  • 7.5. Restoration of Volume/ Fullness
  • 7.6. Others

8. Facial Aesthetics Market - By End-User

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-User
    • 8.1.2. Market Attractiveness Index, By End-User
  • 8.2. Hospitals*
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis, US$ Million, 2018-2026 and Y-o-Y Growth Analysis (%), 2020-2027
  • 8.3. Specialty & Dermatology Clinics
  • 8.4. Others

9. Facial Aesthetics Market - By Region

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Region
    • 9.1.2. Market Attractiveness Index, By Region
  • 9.2. North America
    • 9.2.1. Introduction
    • 9.2.2. Key Region-Specific Dynamics
    • 9.2.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product
    • 9.2.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 9.2.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-User
    • 9.2.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 9.2.6.1. The U.S.
      • 9.2.6.2. Canada
      • 9.2.6.3. Mexico
  • 9.3. South America
    • 9.3.1. Introduction
    • 9.3.2. Key Region-Specific Dynamics
    • 9.3.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product
    • 9.3.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 9.3.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-User
    • 9.3.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 9.3.6.1. Brazil
      • 9.3.6.2. Argentina
      • 9.3.6.3. Rest of South America
  • 9.4. Europe
    • 9.4.1. Introduction
    • 9.4.2. Key Region-Specific Dynamics
    • 9.4.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product
    • 9.4.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 9.4.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-User
    • 9.4.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 9.4.6.1. Germany
      • 9.4.6.2. The U.K.
      • 9.4.6.3. France
      • 9.4.6.4. Spain
      • 9.4.6.5. Italy
      • 9.4.6.6. Rest of Europe
  • 9.5. Asia-Pacific
    • 9.5.1. Introduction
    • 9.5.2. Key Region-Specific Dynamics
    • 9.5.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product
    • 9.5.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 9.5.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-User
    • 9.5.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 9.5.6.1. China
      • 9.5.6.2. India
      • 9.5.6.3. Japan
      • 9.5.6.4. Australia
      • 9.5.6.5. Rest of Asia-Pacific
  • 9.6. Middle East & Africa
    • 9.6.1. Introduction
    • 9.6.2. Key Region-Specific Dynamics
    • 9.6.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product
    • 9.6.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 9.6.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-User

10. Facial Aesthetics Market - Competitive Landscape

  • 10.1. Competitive Scenario
  • 10.2. Competitor Strategy Analysis
  • 10.3. Comparative Product Portfolio Analysis
  • 10.4. Market Positioning/Share Analysis
  • 10.5. Mergers and Acquisitions Analysis

11. Facial Aesthetics Market - Company Profiles

  • 11.1. Allergan*
    • 11.1.1. Company Overview
    • 11.1.2. Product Portfolio and Description
    • 11.1.3. Key Highlights
    • 11.1.4. Financial Overview
  • 11.2. Galderma
  • 11.3. Merz Pharmaceuticals GmbH
  • 11.4. Suneva Medical
  • 11.5. Dr. Korman Laboratories Ltd.
  • 11.6. Sinclair Pharma
  • 11.7. Teoxane
  • 11.8. Laboratoires Vivacy SAS (Bloomage Biotechnology)
  • 11.9. LCA Pharmaceutical
  • 11.10. Integra Lifesciences

12. Facial Aesthetics Market - DataM

  • 12.1. Appendix
  • 12.2. About Us and Services
  • 12.3. Contact Us